Euglycemic Diabetic Ketoacidosis in COVID-19 Patient Caused by Empagliflozin: A Case Report from Intensive Care Unit

The novel coronavirus - Severe Acute Respiratory Syndrome coronavirus 2 - is responsible for mainly respiratory disease (COVID-19). On the other hand, Diabetic Ketoacidosis (DKA) is a life-threating complication. The usual form of DKA is caused by insulin deficiency and is characterized by high blood glucose (usually more than 250mg/dl or 14mmol/L), ketonemia, low pH, and low serum bicarbonate. The other form of DKA is the euglycemic DKA, which occurs in patients with blood glucose lower than 250mg/dl (14mmol/L). This case report describes a patient that presented to the intensive care unit with Covid-19 pneumonia and euglycemic DKA.